[HTML][HTML] Breathing control, brain, and bodily self-consciousness: toward immersive digiceuticals to alleviate respiratory suffering

S Betka, D Adler, T Similowski, O Blanke - Biological psychology, 2022 - Elsevier
Breathing is peculiar among autonomic functions through several characteristics. It
generates a very rich afferent traffic from an array of structures belonging to the respiratory …

Pharmacologic interventions for breathlessness in patients with advanced cancer: a systematic review and meta-analysis

JL Feliciano, JM Waldfogel, R Sharma… - JAMA Network …, 2021 - jamanetwork.com
Importance Improved survival in patients with advanced cancer has increased the need for
better understanding of how to manage common symptoms that they may experience, such …

[HTML][HTML] Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines

D Hui, M Maddocks, MJ Johnson, M Ekström, ST Simon… - ESMO open, 2020 - Elsevier
Breathlessness, dyspnoea and shortness of breath are synonymous terms to describe the
'subjective experience of breathing discomfort that consists of qualitatively distinct …

Opioids for breathlessness: a narrative review

MJ Johnson, DC Currow - BMJ supportive & palliative care, 2020 - spcare.bmj.com
Chronic breathlessness is a disabling and distressing condition for which there is a growing
evidence base for a range of interventions. Non-pharmacological interventions are the …

Palliative care for cancer patients during the COVID-19 pandemic, with special focus on lung cancer

JJAO Schoenmaekers, LEL Hendriks… - Frontiers in …, 2020 - frontiersin.org
The COVID-19 pandemic causes a massive shift in the distribution of health care. Due to the
high number of patients needing hospitalization and even intensive care unit (ICU) …

Effectiveness and safety of opioids on breathlessness and exercise endurance in patients with chronic obstructive pulmonary disease: A systematic review and meta …

M Liu, W Xiao, L Du, Y Yu, X Chen… - Palliative …, 2023 - journals.sagepub.com
Background: Opioids are recommended to treat advanced refractory dyspnoea despite
optimal therapy by the American Thoracic Society clinical practice guidelines, while newly …

l-Menthol–a new treatment for breathlessness?

M Kanezaki, K Terada, S Ebihara - Current Opinion in Supportive …, 2021 - journals.lww.com
The effect of l-menthol on the sensory-emotional dimensions of laboratory-induced
breathlessness in patients with COPD has been described in a clinical trial. Further studies …

How successful is parenteral oxycodone for relieving terminal cancer dyspnea compared with morphine? A multicenter prospective observational study

M Mori, T Kawaguchi, K Imai, N Yokomichi… - Journal of Pain and …, 2021 - Elsevier
Context Parenteral morphine is widely used for dyspnea of imminently dying cancer patients
(terminal dyspnea). However, the efficacy of other opioids such as oxycodone remains …

Palliation of chronic breathlessness with morphine in patients with fibrotic interstitial lung disease–a randomised placebo-controlled trial

S Kronborg-White, CU Andersen, C Kohberg… - Respiratory …, 2020 - Springer
Background Patients suffering from fibrotic interstitial lung diseases (fILD) have a poor
prognosis and a high symptom burden. Palliative treatment includes relief of symptoms such …

[HTML][HTML] Should opioids be used for breathlessness and in whom? A PRO and CON debate of the evidence

M Ekström, DJA Janssen - Current opinion in supportive and …, 2023 - journals.lww.com
Should opioids be used for breathlessness and in whom? A PRO... : Current Opinion in
Supportive and Palliative Care Should opioids be used for breathlessness and in whom? A …